Cardiogenesis Corporation

Cardiogenesis Corporation provides minimally invasive endocardial revascularization fiber optic delivery, robotic handpiece delivery, and a complete console and cardiovascular delivery system. Additionally, it offers compensation services. It pioneered the development of the Transmyocardial Revascularization (TMR) procedure, a method for treating refractory angina, which has been approved by the American College of Cardiology, the American Heart Association, and the Society of Thoracic Surgeons.